Poolbeg Pharma presents at the Proactive One2One Investor Forum - October 6th 2022
Poolbeg Pharma PLC (AIM:POLB) (OTCQB:POLBF) at the Proactive One2One Virtual Forum
Poolbeg Pharma PLC presenting at the One2One Forum 26th April 2022
Faron Pharmaceuticals presents at the Proactive One2One Investor Forum - October 6th 2022
Proactive ONE2ONE #Virtual #Investor Forum - Thursday 14th July 2022
Poolbeg Pharma: Shareholder Q&A
Roquefort Therapeutics presents at the Proactive One2One Investor Forum - October 6th 2022
Poolbeg Pharma 'show first evidence of expansion of R&D pipeline'
Coro Energy present at the Proactive One2One Investor Forum - September 28th 2022
Hartshead Resources present at the Proactive One2One Investor Forum - September 28th 2022
Warpaint London presents at the Proactive One2One Investor Forum - October 6th 2022
Beowulf Mining present at the Proactive One2One Investor Forum - September 28th 2022
Cathal Friel on Results of the proposal to purchase shares from Distribution in Specie shareholders
Poolbeg Pharma upbeat on preliminary influenza drug results
Jeremy Skillington and Proactive Investors - Poolbeg Pharma
GlobalX ETFs, Morganne Delledone - Head of Research - Proactive One2One Investor forum
Tlou Energy present at the Proactive One2One Investor Forum - September 28th 2022
Poolbeg Pharma continues to deliver promised pipeline with second anti-infective licensing deal
Thor Explorations presents at the Proactive One2One Investor Forum - September 28th 2022
Poolbeg Pharma sign licence agreement with AnaBio Technologies to develop oral vaccine platform
